Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Item
http://www.wikidata.org/entity/Q35055665
Peptide Vaccine: Progress and ChallengesVery small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cellsAccumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.Therapeutic Vaccine Strategies against Human Papillomavirus.Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesMechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50).Targeting Myeloid-Derived Suppressor Cells in Cancer.Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?
P2860

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Item
http://www.wikidata.org/entity/Q35055665
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@ast
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@en
type
label
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@ast
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@en
prefLabel
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@ast
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Safety and Immunogenicity of a ...... Human, Proof-of-Concept Trial.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932